Accenture (ACN) Stock Sinks As Market Gains: Here's Why

Accenture (ACN) stock declined 1.4% to $251.99 in a session where broader markets gained, despite the company's 7.11% gain over the past month. Ahead of its September 25, 2025 earnings, where analysts expect Q3 revenue growth of 5.6% and EPS growth of 6.81%, ACN holds a Zacks Rank #4 (Sell) due to recent slight negative EPS estimate revisions. The stock trades at a Forward P/E of 18.72, a premium to its industry average of 17.03, and its Computers - IT Services industry is ranked in the bottom 37% by Zacks, signaling potential challenges despite projected growth.

Analysis

Accenture (ACN) presents a mixed financial picture, characterized by short-term momentum clashing with cautious forward-looking indicators. Despite a recent daily decline of 1.4% to $251.99, the stock has outperformed its sector and the broader market over the past month with a 7.11% gain. Analyst consensus for the upcoming quarter projects healthy year-over-year growth, with earnings per share expected to rise 6.81% to $2.98 and revenue to increase 5.6% to $17.33 billion. However, this optimism is tempered by the full-year forecast, which anticipates a significant deceleration to 0% revenue growth, even as full-year EPS is expected to grow 7.78%. This discrepancy, coupled with a minor downward revision of 0.01% in the Zacks Consensus EPS estimate over the last month, has resulted in a bearish Zacks Rank of #4 (Sell). From a valuation standpoint, ACN trades at a Forward P/E of 18.72, a premium to its industry's average of 17.03, while its PEG ratio of 2.19 matches the industry average. This valuation premium exists within the context of a weak industry, ranked in the bottom 37% by Zacks, suggesting potential vulnerability if growth forecasts are not met or revised downwards.

Key Decisions for Investors

• Investors should exercise caution given the conflicting signals of strong monthly performance against a Zacks #4 (Sell) rating, flat full-year revenue guidance, and a premium valuation.
• Pay close attention to the upcoming September 25th earnings report, specifically management's updated full-year revenue outlook, as any deviation from the current 0% growth forecast will be a significant catalyst for the stock.
• Considering the stock's valuation premium and the weak outlook for its industry, current holders may find it prudent to review their positions and consider trimming ahead of the earnings release to mitigate downside risk.